5FK-94043-48932
4 vaccinations
1 coded response
34 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 537 / WI
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
- 2020-12-16
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-25
- 2020-12-30
- 2021-01-06
-
2021-01-07
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-13
- 2021-01-16
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-04-08
- 2021-07-08
-
2021-11-13
Dose 3 — Pfizer-BioNTech
-
2022-01-07
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-10
-
2022-10-13
Dose 4 — Pfizer-BioNTech
-
2022-10-15
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-11-10
- 2022-11-17
- 2022-11-24
- 2023-01-12
- 2023-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-11-13 | Pfizer-BioNTech | No |
| 4 | 2022-10-13 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-09 | priority 2/3 | |
| 2022-01-07 | Unsuccessful |
Free text
Release 10 — 12 months, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release